RaySearch Laboratories AB (publ) (RAY-B) - Cash Flow Conversion Efficiency
Based on the latest financial reports, RaySearch Laboratories AB (publ) (RAY-B) has a cash flow conversion efficiency ratio of 0.112x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr116.90 Million ≈ $12.58 Million USD) by net assets (Skr1.04 Billion ≈ $112.22 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See debt-free asset ratio of RaySearch Laboratories AB (publ) to measure how much of total assets are equity-financed.
RaySearch Laboratories AB (publ) - Cash Flow Conversion Efficiency Trend (2003–2025)
This chart illustrates how RaySearch Laboratories AB (publ)'s cash flow conversion efficiency has evolved over time, based on yearly financial data. Check RaySearch Laboratories AB (publ) cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
RaySearch Laboratories AB (publ) Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of RaySearch Laboratories AB (publ) ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Far East Holdings Bhd
KLSE:5029
|
0.088x |
|
AB S.A.
WAR:ABE
|
-0.046x |
|
HANSEN TECHNOLOGIES LTD.
F:H2T
|
N/A |
|
Onterris
NYSE:ONT
|
-0.026x |
|
Fujian Raynen Tech Co Ltd
SHG:603933
|
0.037x |
|
Peapack-Gladstone Financial
NASDAQ:PGC
|
0.055x |
|
Civista Bancshares Inc
NASDAQ:CIVB
|
0.021x |
|
Svolder AB (publ)
ST:SVOL-B
|
0.002x |
Annual Cash Flow Conversion Efficiency for RaySearch Laboratories AB (publ) (2003–2025)
The table below shows the annual cash flow conversion efficiency of RaySearch Laboratories AB (publ) from 2003 to 2025. For the full company profile with market capitalisation and key ratios, see RaySearch Laboratories AB (publ) market cap and net worth.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | Skr985.30 Million ≈ $106.03 Million |
Skr387.00 Million ≈ $41.65 Million |
0.393x | -29.03% |
| 2024-12-31 | Skr876.71 Million ≈ $94.35 Million |
Skr485.23 Million ≈ $52.22 Million |
0.553x | -10.75% |
| 2023-12-31 | Skr735.23 Million ≈ $79.12 Million |
Skr455.93 Million ≈ $49.07 Million |
0.620x | +14.22% |
| 2022-12-31 | Skr657.16 Million ≈ $70.72 Million |
Skr356.78 Million ≈ $38.39 Million |
0.543x | +48.01% |
| 2021-12-31 | Skr649.28 Million ≈ $69.87 Million |
Skr238.16 Million ≈ $25.63 Million |
0.367x | -23.17% |
| 2020-12-31 | Skr694.35 Million ≈ $74.72 Million |
Skr331.51 Million ≈ $35.68 Million |
0.477x | +5.21% |
| 2019-12-31 | Skr705.47 Million ≈ $75.92 Million |
Skr320.14 Million ≈ $34.45 Million |
0.454x | +67.17% |
| 2018-12-31 | Skr657.45 Million ≈ $70.75 Million |
Skr178.47 Million ≈ $19.21 Million |
0.271x | +6.84% |
| 2017-12-31 | Skr580.42 Million ≈ $62.46 Million |
Skr147.48 Million ≈ $15.87 Million |
0.254x | -3.24% |
| 2016-12-31 | Skr460.19 Million ≈ $49.52 Million |
Skr120.85 Million ≈ $13.01 Million |
0.263x | -24.70% |
| 2015-12-31 | Skr319.52 Million ≈ $34.39 Million |
Skr111.43 Million ≈ $11.99 Million |
0.349x | +74.49% |
| 2014-12-31 | Skr251.55 Million ≈ $27.07 Million |
Skr50.27 Million ≈ $5.41 Million |
0.200x | +25.60% |
| 2013-12-31 | Skr196.60 Million ≈ $21.16 Million |
Skr31.28 Million ≈ $3.37 Million |
0.159x | -60.42% |
| 2012-12-31 | Skr217.55 Million ≈ $23.41 Million |
Skr87.45 Million ≈ $9.41 Million |
0.402x | +133.57% |
| 2011-12-31 | Skr196.70 Million ≈ $21.17 Million |
Skr33.85 Million ≈ $3.64 Million |
0.172x | -46.06% |
| 2010-12-31 | Skr196.76 Million ≈ $21.17 Million |
Skr62.78 Million ≈ $6.76 Million |
0.319x | +19.87% |
| 2009-12-31 | Skr184.86 Million ≈ $19.89 Million |
Skr49.21 Million ≈ $5.30 Million |
0.266x | +53.75% |
| 2008-12-31 | Skr150.44 Million ≈ $16.19 Million |
Skr26.05 Million ≈ $2.80 Million |
0.173x | -36.96% |
| 2007-12-31 | Skr137.85 Million ≈ $14.83 Million |
Skr37.86 Million ≈ $4.07 Million |
0.275x | +7.77% |
| 2006-12-31 | Skr118.07 Million ≈ $12.71 Million |
Skr30.09 Million ≈ $3.24 Million |
0.255x | -49.60% |
| 2005-12-31 | Skr81.85 Million ≈ $8.81 Million |
Skr41.39 Million ≈ $4.45 Million |
0.506x | +28.56% |
| 2004-12-31 | Skr32.72 Million ≈ $3.52 Million |
Skr12.87 Million ≈ $1.39 Million |
0.393x | +11.83% |
| 2003-12-31 | Skr19.82 Million ≈ $2.13 Million |
Skr6.97 Million ≈ $750.30K |
0.352x | -- |
About RaySearch Laboratories AB (publ)
RaySearch Laboratories AB (publ), a medical technology company, provides software solutions for cancer treatment worldwide. It offers RayStation, a treatment planning system for cancer centers; RayCare, an oncology information system for clinics; RayIntelligence, cloud-based oncology analytics system that cancer centers can use to gather, structure and analyze data; and RayCommand, a treatment co… Read more